cobas 8000 Core Unit
Device Core Lab
PDI 04015630928330
General payments
$29,319
Research payments
$506,727
Through program year 2025, $29,319 in general payments and $506,727 in research payments were reported against cobas 8000 Core Unit (Core Lab).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $297 | 6 |
| 2023 | General | $17,128 | 6 |
| 2023 | Research | $9,507 | 2 |
| 2022 | General | $2,577 | 10 |
| 2022 | Research | $211,879 | 2 |
| 2021 | General | $9,318 | 8 |
| 2021 | Research | $285,341 | 2 |
Breakdown
The top 5 of 6 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
30 general · 6 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.